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Abstract.	
	
Ischemic	stroke	remains	one	of	the	most	urgent	health	and	social	problems	
as	well	as	the	leading	cause	of	disability	in	neurological	patients.	
The	objective	of	 the	 research	was	 to	study	and	evaluate	 the	efficiency	of	
complex	 therapy	using	choline	alphoscerate	and	vincamine	 in	patients	during	
the	early	recovery	period	of	ischemic	stroke	considering	the	processes	of	energy	
metabolism.	
Materials	 and	 methods.	 The	 study	 involved	 66	 patients	 in	 the	 early	
recovery	period	of	primary	hemispheric	ischemic	stroke	being	randomized	into	
2	 groups.	 Group	 1	 received	 basic	 therapy	 for	 secondary	 prevention	 of	 stroke.	
Patients	of	Group	2	received	choline	alphoscerate	and	vincamine	for	2	months	in	
addition	 to	basic	 therapy.	The	evaluation	of	neurological	deficit	and	 functional	
status	of	patients	was	carried	out	using	the	NIH	Stroke	Scale,	the	Scandinavian	
stroke	scale	(SSS)	and	the	Barthel	Index;	the	concentration	of	lactic	and	pyruvic	
acid	in	serum	was	determined.	
Results.	After	treatment	the	NIH	Stroke	Scale	score	decreased	significantly	
by	17.7%,	 the	SSS	score	 increased	by	22.7%	and	 the	Barthel	 Index	 increased	by	
16.2%	 	 in	Group	2	 (p<0.05).	There	was	detected	a	moderate	 correlation	 (r=0.34;	
p=0.031)	between	 the	 lactate	 level	and	 the	NIH	Stroke	Scale	 score	as	well	as	a	
moderate	 inverse	 correlation	 between	 the	 lactate	 level	 and	 the	 SSS	 score	 (r=-
0.42;	 p=0.032)	 one	 month	 after	 stroke.	 In	 addition,	 3	 months	 	 after	 stroke	
increased	 initial	 lactate	 level	 correlated	 inversely	 with	 the	 SSS	 score	 (r=-0.41;	
p=0.036)	and	the	lactate-to-pyruvate	ratio	correlated	with	the	SSS	score	(r=-0.47;	
p=0.039)	and	the	Barthel	Index	(r=-0.29;	p=0.046).		
Conclusions.	Early	recovery	period	of	 ischemic	stroke	 is	characterized	by	
the	disorders	of	energy	metabolism,	 signs	of	activation	of	anaerobic	glycolysis	
with	 increased	serum	 levels	of	 lactate	and	 lactate-to-pyruvate	ratio	which	may	
be	 predictors	 of	 unfavourable	 functional	 outcome.	 Complex	 therapy	 using	
choline	 alphoscerate	 and	 vincamine	 can	 contribute	 to	 the	 normalization	 of	
energy	 metabolism	 as	 well	 as	 to	 the	 reduction	 in	 clinical	 manifestations	 of	
neurological	disorders.	
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Problem	statement	and	analysis	of	the	recent	research	
Ischemic	stroke	 (IS)	remains	one	of	 the	most	urgent	health	and	social	problems	nowadays.	
Stroke	ranks	first	as	the	leading	cause	of	primary	disability	in	neurological	patients	[4].	
The	 priority	 of	 treatment	 of	 post-stroke	 patients	 is	 their	 rehabilitation	 and	 social	
readaptation.	 Maximal	 recovery	 is	 possible	 within	 the	 first	 6	 months	 after	 stroke.	 The	 leading	
mechanism	of	recovering		impaired	functions	is	neuroplasticity	[1].	
Neuroplasticity	 is	perfomed	mainly	 through	 the	mechanisms	of	synaptic	stabilization	with	
changes	 in	synaptic	 functions,	 	 length	and	configuration	of	 their	active	zones,	 formation	of	new	
synapses,	 regulation	 of	 effective	 synaptic	 transmission,	 changes	 in	 excitability	 threshold	 of	
voltage-sensitive	membrane	channels	 [1,	6].	These	processes	 require	significant	energy	 reserves,	
therefore,	 stimulation	 of	 metabolic	 processes	 in	 neurons	 and	 provision	 of	 	 adequate	 perfusion	
through	 the	 optimization	 of	 cerebral	 hemodynamics	 become	 a	 prerequisite	 for	 the	 efficient	
recovery	of	impaired	functions.	
Among	 neuroprotectors	 choline	 alphoscerate	 which	 is	 decomposed	 into	 choline	 and	
glycerophosphate	within	the	body,	requires	special	attention.	Free	choline	is	metabolized	and	then	
eliminates	 acetylcholine	 deficiency	 stimulating	 cholinergic	 synaptic	 neurotransmission.	
Glycerophosphate	being	a	precursor	of	phosphatidylcholine	contributes	to	stabilization	of	neuronal	
and	 mitochondrial	 membranes	 [3].	 Vincamine	 has	 selective	 vasoregulative	 effect	 on	 cerebral	
vessels;	it	facilitates	the	adaptation	of	blood	flow	to	the	brain’s	metabolic	needs	and	can	increase	
the	efficiency	of	glucose	and	oxygen	absorption	by	brain	tissue,	thus	shifting	glucose	metabolism	
towards	 aerobic	 glycolysis	 being	 more	 energy	 efficient	 [2].	 Therefore,	 the	 combination	 of	 these	
drugs	may	help	stimulate	the	neuroplasticity	and	reach	the	maximal	effect	in	recovery	of	impaired	
functions	when	treating	patients	after	stroke.	
The	objective	of	 the	 research	was	 to	study	and	evaluate	 the	efficiency	of	complex	 therapy	
using	choline	alphoscerate	and	vincamine	in	patients	during	the	early	recovery	period	of	ischemic	
stroke	considering	the	processes	of	energy	metabolism	
	
Materials	and	methods	
The	study	involved	66	 	(41	males	and	25	females;	the	average	age	was	56.23±2.96)	patients	in	
the	early	recovery	period	of	primary	hemispheric	 ischemic	stroke.	Stroke	was	centered	 in	the	 left	
brain	 hemisphere	 in	 38	 (57.6%)	 patients	 and	 in	 28	 (42.4%)	 patients	 it	 was	 found	 in	 the	 right	
hemisphere.	 Exclusion	 criteria	 were:	 hemorrhagic	 stroke,	 recurrent	 stroke,	 posterior	 circulation	
stroke,	decompensated	somatic	pathology.	The	control	group	 (CG)	consisted	of	15	persons	of	 the	
same	age	and	sex		without	history	of	stroke	and	severe	somatic	pathology.	
The	 study	 was	 performed	 in	 the	 vascular	 neurology	 department	 of	 the	 Ivano-Frankivsk	
Regional	 Clinical	 Hospital.	 Before	 the	 involvement	 into	 the	 study	 all	 patients	 signed	 informed	
consent.	Patients	were	selected	in	the	acute	period	of	IS.	After	discharge	from	the	hospital	2	visits	
including	examinations	of	patients	were	performed	1	and	3	months	after	IS.	
Patients	 were	 randomized	 into	 2	 groups	 using	 a	 series	 of	 random	 numbers.	 Group	 1	 (34	
patients,	 average	 age	 -	 55.51±2.63)	 received	 basic	 therapy	 for	 secondary	 prevention	 of	 stroke	
(antiplatelet,	 antihypertensive	 and	 lipid-lowering	 drugs)	 according	 to	 the	 Order	 of	 Ministry	 of	
Health	of	Ukraine	 	of	August	3,	2012	No	602.	Group	2	(32	patients,	average	age	57.45±2.38)	received	
1	tablet		of	choline	alphoscerate	at	a	dose	of	400	mg	twice	a	day	and	1	tablet	of	vincamine	at	a	dose	
of	30	mg	twice	a	day	within	two	months	in	addition	to	basic	therapy.	
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Clinical	 and	neurological	 examination	of	patients	was	performed	using	 specially	designed	
scheme.	The	evaluation	of	neurological	deficit	and	 functional	 status	of	patients	was	 carried	out	
using	the	NIH	Stroke	Scale	(NIHSS),	the	Scandinavian	stroke	scale	(SSS)	and	the	Barthel	Index	(BI);		
The	concentration	of	 lactic	and	pyruvic	acid	 in	 serum	was	determined	by	 the	colorimetric	
method	using	the	wavelength	range	of	565	nm	and	440	nm,	respectively.	
Statistical	 analysis	of	 the	 results	was	 carried	out	with	 the	help	of	 statistical	data	 analysis	
software	“Statistica”	and	“MS	Excel”	using	parametric	and	nonparametric	evaluation	methods.	
	
Results	and	discussion	
When	examining	neurological	status	 in	patients	according	 to	 the	NIHSS	and	SSS	3	months	
after	IS	positive	dynamics	in	both	groups	of	patients	was	observed	(Table	1).	In	Group	1	the	NIHSS	
score	decreased	by	9.6%	being	initially	7.36±0.65;	in	Group	2	it	decreased	by	17.7%,	however,	these	
changes	 were	 statistically	 significant	 only	 in	 Group	 2	 (p<0.05).	 A	 significant	 increase	 in	 the	 SSS	
score	by	22.7%	and	the	BI	by	16.2%	compared	to	the	initial	level	was	observed	in	Group	2	(p<0.05).	
	
Table	1	
Dynamics	of	indicators	of	neurological	deficit,	M±m	
Scale	
Group	1	 Group	2	
1	month	 3	months	 1	month	 3	months	
NIHSS	 7.36±0.65	 6.65±0.61	 7.41±0.69	 6.12±0.58*	
SSS	 40.5±1.84	 45.8±2.43	 39.4±1.76	 48.1±2.28*	
BI	 76.0±2.16	 82.0±2.98	 71.0±2.34	 82.5±3.09*	
Note:	
*	-	p<0.05	compared	to	the	indicators	before	treatment	
	
The	 indicators	 of	 energy	 metabolism	 in	 post-stroke	 patients	 differed	 from	 the	 CG	 due	 to	
increased	lactate	concentration	and	lactate-to-pyruvate	ratio	in	blood	(p<0.05)	(Table	2).	High	levels	
of	 lactic	 acid	 and	 lactate-to-pyruvate	 ratio	 demonstrated	 shifting	 the	 processes	 of	 energy	
metabolism	 towards	 less	 energy	 efficient	 anaerobic	 glycolysis,	 that	 may	 be	 a	 result	 of	 cerebral	
hypoperfusion	 and	 insufficient	 oxygenation	 of	 brain	 tissue	 [7].	 The	 level	 of	 pyruvate	 within	 3	
months	 after	 IS	 in	 both	 groups	 was	 not	 significantly	 different	 from	 that	 in	 the	 CG	 (p>0.05),	
therefore,	 dynamics	 of	 lactate-to-pyruvate	 ratio	 was	 caused	 by	 changes	 in	 lactic	 acid	
concentration.	After	treatment	a	significant	decrease	in	the	level	of	lactate	and,	consequently,	the	
lactate-to-pyruvate	 ratio	 was	 observed	 in	 patients	 of	 Group	 2	 indicating	 the	 optimization	 of	
metabolic	processes	under	the	influence	of	therapy.	
	
Table	2	
Dynamics	of	serum	levels	of	lactate	and	pyruvate,	M±m	
Indicator	 Time	 Lactate,	mmol/l	 Pyruvate,	mmol/l	
Lactate-to-
pyruvate	
CG	 0.128±0.036	 0.0276±0.0064	 4.64±0.93	
Group	1	
1	month	 0.482±0.057*	 0.0271±0.0071	 17.79±1.94*	
3	months	 0.34±0.039*	 0.028±0.0074	 12.14±0.87*#	
Group	2	
1	month	 0.489±0.059*	 0.264±0.0069	 18.52±2.09*	
3	months	 0.22±0.041*#^	 0.028±0.071	 7.85±0.88*#^	
Note:	
*	-	p<0.05	compared	to	the	control	group;	
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#	-	p<0.05	compared	to	the	indicators	before	treatment;	
	^-	p<0.05	compared	to	the	indicators	of		Group	1	
The	analysis	of	the	obtained	results	showed	a	relationship	between	the	parameters	of	energy	
metabolism	and	manifeststions	of	neurological	deficit	 (Table	3).	There	was	detected	a	moderate	
correlation	 (r=0.34;	p=0.031)	between	 the	 lactate	 level	and	 the	NIHSS	score	as	well	as	a	moderate	
inverse	correlation	between	the	 lactate	 level	and	the	SSS	score	 (r=-0.42;	p=0.032)	one	month	after	
stroke.	Similar	tendencies	were	observed	between	the	lactate-to-pyruvate	ratio	and	the	NIHSS	and	
SSS	scores.	 In	addition,	3	months	 	after	stroke	 increased	 initial	 lactate	 level	correlated	 inversely	
with	the	SSS	score	(r=-0.41;	p=0.036)	and	the	lactate-to-pyruvate	ratio	correlated	with	the	SSS	score	
(r=-0.47;	p=0.039)	and	the	Barthel	Index	(r=-0.29;	p=0.046).	
	
Table	3	
Correlation	between	the	initial	parameters	of	energy	metabolism	and	manifestations	of	
neurological	deficit	in	dynamics	
Indicator	 Time	 Lactate	 Lactate-to-pyruvate	
NIHSS	
1	month	 r=0.34	(p=0.031)*	 r=0.37	(p=0,039)*	
3	months	 r=0.36	(p=0.058)	 r=0.41	(p=0.056)	
SSS	
1	month	 r=-0.42	(p=0.032)*	 r=-0.44	(p=0.042)*	
3	months	 r=-0.41	(p=0.036)*	 r=-0.47	(p=0.039)*	
BI	
1	month	 r=-0.27	(p=0.061)	 r=-0.31	(p=0.065)	
3	months	 r=-0.22	(p=0.059)	 r=-0.29	(p=0.046)*	
Note:	*	-	significance	of	correlation	(p<0.05).	
	
Changes	in	lactate	concentration	were	accompanied	by	a	moderate	inverse	correlation	with	
the	SSS	score	(r=-0.34;	p=0.032),	and	changes	in	the	lactate-to-pyruvate	ratio	correlated	significantly	
(p<0.05)	with	dynamics	of	neurological	deficit	assessed	by	the	NIHSS,	the	SSS	and	the	BI	(Table	4).	
	
Table	4	
Correlation	between	dynamics	of	indicators	of	energy	metabolism	and	manifestations	of	
neurological	deficit	
Indicator	 Lactate	 Lactate-to-pyruvate	
NIHSS	 r=0.29	(p=0.057)	 r=0.31	(p=0.042)*	
SSS	 r=-0.34(p=0.032)*	 r=-0.39	(p=0.034)*	
BI	 r=-0.18(p=0.072)	 r=-0.21	(p=0.046)*	
Note:	*	-	significance	of	correlation	(p<0.05).	
	
The	 obtained	 results	 may	 indicate	 that	 the	 early	 recovery	 period	 of	 IS	 is	 characterized	 by	
manifestations	of	the	disorders	of	energy	metabolism	with	the	tendency	to	activation	of	anaerobic	
glycolysis.	 It	 causes	 lack	 of	 neuronal	 energy	 supply	 since	 anaerobic	 glycolysis	 results	 in	 the	
formation	of	fewer	number	of	ATP	molecules	in	comparison	with	the	aerobic	one	[5].	These	changes	
may	have	a	negative	influence	on	the	course	of	the	IS	recovery	period.	Therefore,	increased	serum	
levels	of	 lactate	being	a	major	metabolite	of	anaerobic	glycolysis,	and	 lactate-to-pyruvate	 ratio	1	
month	 after	 IS	 may	 be	 predictors	 of	 unfavourable	 functional	 outcome	 requiring	 specific	
pharmacological	 correction	 [7,	 8].	 Complex	 therapy	 using	 choline	 alphoscerate	 and	 vincamine	
contributes	 to	 the	 normalization	 of	 energy	 metabolism	 which	 correlates	 with	 the	 reduction	 in	
clinical	manifestations	of	neurological	disorders.	Thus,	 the	use	of	 these	drugs	may	contribute	 to	
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better	 recovery	 of	 impaired	 functions	 as	 well	 as	 increase	 the	 efficiency	 of	
the	complex	of	rehabilitation	measures	in	patients	after	IS.	
	
Conclusions	
1. The	 early	 recovery	 period	 of	 ischemic	 stroke	 is	 characterized	 by	 the	 disorders	 of	 energy	
metabolism,	signs	of	activation	of	anaerobic	glycolysis.	
2. Increased	serum	levels	of	lactate	and	lactate-to-pyruvate	ratio	1	month	after	stroke	may	be	
predictors	of	less	effective	recovery	and	unfavourable	functional	outcome.	
3. Complex	 therapy	 using	 choline	 alphoscerate	 and	 vincamine	 can	 contribute	 to	 the	
normalization	of	energy	metabolism	as	well	as	 to	 the	reduction	 in	clinical	manifestations	
of	neurological	disorders.	
	
Prospects	for	further	research	
Correction	 of	 the	 disorders	 of	 energy	 metabolism	 may	 enhance	 the	 efficiency	 of	
rehabilitation	in	patients	in	the	early	recovery	period	of	ischemic	stroke;	it	requires	further	studies	
involving	a	larger	number	of	patients.	
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